ATI RN
Cardiovascular System Exam
1. Which of the following conditions is characterized by inflammation of the heart muscle, often due to a viral infection, leading to impaired heart function?
- A. Myocarditis
- B. Endocarditis
- C. Pericarditis
- D. Cardiomyopathy
Correct answer: A
Rationale: The correct answer is A, Myocarditis. Myocarditis is an inflammation of the heart muscle, typically caused by a viral infection. It can impair the heart's ability to pump blood efficiently, potentially leading to other complications. Endocarditis (choice B) is an inflammation of the inner lining of the heart chambers and valves. Pericarditis (choice C) is inflammation of the pericardium, the outer lining of the heart. Cardiomyopathy (choice D) is a disease of the heart muscle that affects the heart's ability to pump blood.
2. Which of the following is a central vasodilator and peripheral vasoconstrictor?
- A. Sympathetic nervous system
- B. Parasympathetic nervous system
- C. Norepinephrine
- D. Acetylcholine
Correct answer: A
Rationale: The correct answer is the Sympathetic nervous system. The sympathetic nervous system is a branch of the autonomic nervous system that is responsible for the fight-or-flight response. It causes vasodilation in central vessels to increase blood flow to vital organs during stress or exercise, while inducing vasoconstriction in peripheral vessels to redirect blood to essential areas. Norepinephrine and acetylcholine are neurotransmitters associated with the sympathetic and parasympathetic nervous systems, respectively, but they are not themselves central vasodilators and peripheral vasoconstrictors.
3. The client on amiodarone reports shortness of breath. What is the nurse’s best response?
- A. Notify the healthcare provider immediately.
- B. Reassure the client that this is a common side effect.
- C. Instruct the client to monitor their symptoms at home.
- D. Suggest the client reduce physical activity.
Correct answer: A
Rationale: When a client on amiodarone reports shortness of breath, it can be indicative of pulmonary toxicity, a severe side effect associated with this medication. The nurse's priority is to notify the healthcare provider immediately to assess the situation and determine the appropriate course of action. Choice B is incorrect because shortness of breath with amiodarone should not be dismissed as a common side effect. Instructing the client to monitor symptoms at home (Choice C) may delay necessary intervention. Suggesting the client reduce physical activity (Choice D) does not address the potential serious nature of the symptom and the need for prompt evaluation.
4. Which procedure is used to remove excess fluid or air from the pleural space, helping to relieve pressure on the lungs?
- A. Thoracentesis
- B. Bronchoscopy
- C. Chest X-ray
- D. Arterial blood gas (ABG)
Correct answer: A
Rationale: The correct answer is Thoracentesis. Thoracentesis is a procedure specifically designed to remove excess fluid or air from the pleural space in the chest. This process helps to relieve pressure on the lungs and improve breathing. Bronchoscopy (Choice B) is a procedure used to visualize the airways and diagnose lung conditions, not to remove fluid from the pleural space. Chest X-ray (Choice C) is an imaging test that provides a picture of the structures inside the chest, including the lungs, heart, and bones. Arterial blood gas (ABG) test (Choice D) is a blood test that measures the levels of oxygen and carbon dioxide in the blood, providing information about how well the lungs are working, but it does not involve removing excess fluid or air from the pleural space.
5. The client on warfarin has an INR of 1.2. What is the nurse’s priority action?
- A. Increase the dose of warfarin
- B. Administer vitamin K
- C. Monitor for signs of bleeding
- D. Hold the next dose and notify the healthcare provider
Correct answer: A
Rationale: The correct answer is to increase the dose of warfarin. An INR of 1.2 is below the therapeutic range for a client on warfarin, indicating that the dose is subtherapeutic. The priority action in this situation is to adjust the dose to achieve the target therapeutic INR range (usually 2-3) to prevent thromboembolic events. Administering vitamin K is not necessary as the INR is low, and there are no signs of bleeding. Monitoring for signs of bleeding is important but not the priority in this case since the INR is subtherapeutic. Holding the next dose and notifying the healthcare provider would delay the intervention needed to adjust the dose and achieve the therapeutic range.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access